This announcement is a separate document:
大塚ホールディングス:抗精神病薬「レキサルティ」 日本における効能追加の承認取得について
Otsuka Holdings: Obtaining approval for additional efficacy of the antipsychotic drug “Lexarti” in Japan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.